Aarti Pharmalabs Ltd
BSE: 543748
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 579.70+36.3% | 425.25+1.9% | 417.29+11.2% | 375.31-29.1% | 529.62+12.5% | 470.95+24.8% | 377.29 |
| Other Income | 10.53+2936.8% | -0.37-111.8% | 3.15+97.3% | 1.60+163.7% | -2.50-121.0% | 11.94+305.0% | 2.95 |
| Total Income | 590.23+38.9% | 424.88+1.1% | 420.44+11.5% | 376.91-28.5% | 527.12+9.2% | 482.88+27.0% | 380.24 |
| EXPENSES | |||||||
| Expenditure | 507.65+39.7% | 363.51-4.0% | 378.74+22.3% | 309.73-25.1% | 413.62+7.0% | 386.70+22.1% | 316.81 |
| Tax | 20.55+39.5% | 14.74+36.8% | 10.77-32.5% | 15.95-35.3% | 24.66+8.8% | 22.66+45.3% | 15.60 |
| PROFIT | |||||||
| PBT | 82.59+41.0% | 58.58+40.5% | 41.70-37.9% | 67.17-40.8% | 113.50+18.0% | 96.18+51.6% | 63.43 |
| Net Profit | 62.03+41.5% | 43.84+41.8% | 30.93-39.6% | 51.22-42.3% | 88.85+20.8% | 73.52+53.7% | 47.84 |
| KEY METRICS | |||||||
| OPM % | 20.20%-3.35pp | 23.55%+5.82pp | 17.73%-7.62pp | 25.35%-1.67pp | 27.02%+15.66pp | 11.36%+1.77pp | 9.59% |
| NPM % | 10.51%+0.19pp | 10.32%+2.96pp | 7.36%-6.23pp | 13.59%-3.26pp | 16.85%+1.62pp | 15.23%+2.65pp | 12.58% |
| EPS | 6.84+41.3% | 4.84+41.9% | 3.41 | 0.00-100.0% | 9.80+20.8% | 8.11+53.6% | 5.28 |
Corporate Events
Board MeetingAARTIPHARM
202413May
Board Meeting
Consider and approve Audited Financial Results for the quart…
BSE Filing ↗ Board MeetingAARTIPHARM
20247Feb
Board Meeting
Consider and approve Audited Financial Results for the quart…
BSE Filing ↗ Board MeetingAARTIPHARM
20237Nov
Board Meeting
Consider and approve Audited Financial Results for the quart…
BSE Filing ↗